Stock Updates

How has Fresenius Medical Care AG & Co. KGAA:(NYSE:FMS) performed recently?

Fresenius Medical Care AG & Co. KGAA (NYSE: FMS) is a large market cap stock with a market cap of 28055.09. It is in the Specialized Health Services industry and sector Healthcare, with a current P/E of 24.53, a forward P/E of 19.67 and EPS of 1.8. At a stock price of 44.26 (0.61%) it has a dividend yield of 1.02%.

EPS growth for the last five years have been 15.90%, more recently this last year it has grown by -2.00%. The next year growth is going to be about 11.83% and more long-term 9.60% after five years. EPS growth quarter over quarter is 21.90%. Sales growth for the past five years have been 7.20% and sales growth quarter over quarter is 5.30%.

For performance, Fresenius Medical Care AG & Co. KGAA the past week has seen a gain of -1.67%. For the last month performance for Fresenius Medical Care AG & Co. KGAA is -5.53%. While the last quarter is 8.35% and half year, 4.52%. Finally for the year, performance is 10.16%.

The 52-week high for Fresenius Medical Care AG & Co. KGAA, is at -6.86%, and for the 52-week low it comes to a value of 17.33%. The 20-day simple moving average is -1.61% and 3.07% for the 200-day simple moving average.

Volatility for the week is at 1.12%, and for the month it is 1.05%. Fresenius Medical Care AG & Co. KGAA, has a target price of 48.25.

In terms of debt, long term debt/equity is 0.76, and for total debt/equity Fresenius Medical Care AG & Co. KGAA has 0.89. The gross margin is 32.40%, while operating margin is 14.30%, the profit margin is 6.40%. The current ratio is 1.5 and the quick ratio is 1.2.

Insider ownership is at 35.70%, with instituitional ownership at 2.30%. Fresenius Medical Care AG & Co. KGAA has a payout ratio of 22.20%. With the total shares outstanding coming to 633.87. The shares float is 615.27, with the float short at 0.15%, with short ratio coming to 5.03.

In terms of returns, the return on assets see Fresenius Medical Care AG & Co. KGAA, get 4.30%, with its returns on investment at 9.10%. Return on equity is 11.00%. So will the investors see the target price of 48.25, reached soon?

Disclaimer: Remember there is a risk to your investment, this is not a recommendation, nor personal advice, never invest more than you are able too loose.

 

About the author

Peter Clarke

Leave a Comment